Drug · DIN 02510219
CORZYNA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 3, 2021; first marketed May 3, 2021.
- Drug Identification Number (DIN)
- 02510219
- Company (DIN owner)
- Kye Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Ranolazine C01EB18
- Class
- Human
- Record last updated
- July 30, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANOLAZINE | 500 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 31, 2020: NOC 24908New Drug Submission (NDS)
Other DINs named CORZYNA
- DIN 02510227 · Marketed
- DIN 02558947 · Approved
- DIN 02558955 · Approved